Artelo Biosciences, Inc.
ARTL
$1.04
$0.010.97%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.78% | 4.54% | -10.62% | 6.63% | 7.87% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.80% | -45.77% | -72.20% | -84.41% | -81.70% |
| Change in Net Operating Assets | 36.80% | -64.66% | 110.06% | 31.32% | 408.37% |
| Cash from Operations | -1.74% | -6.01% | -20.58% | -10.10% | -2.49% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 121.53% | 290.71% | 198.93% | -47.41% | 18.56% |
| Cash from Investing | 121.53% | 290.71% | 198.93% | -47.41% | 18.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -80.25% | -83.74% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -80.25% | -87.00% | 364.18% | -- | -- |
| Foreign Exchange rate Adjustments | -113.33% | -100.00% | 128.30% | 122.28% | 126.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 88.29% | 138.20% | 24.44% | -66.60% | 22.77% |